Archives

img-01

The Lure of Asia: Lower Costs and Much More

With the growth of Asian economies spurring on the expansion of Asian medical markets, medical and pharmaceutical companies in the West are increasingly looking to Asia for outsourcing. Western medical device and pharmaceutical companies have begun to outsource research and development, clinical... Read More

img-01

India Revises Bioequivalence Guidelines

In a move to ensure standards of quality, efficacy and safety in medical products, India’s Central Drug Standard Control Organization has revised its guidelines on bioequivalence and bioavailability for pharmaceuticals. The revisions will become part of Schedule Y of the Drugs and... Read More

img-01

Unregulated Stents in India Poses Threat to Consumers

Drug-eluting stents (DES) are designed for the controlled release of drugs into surrounding tissue. These types of stents are particularly useful in preventing the re-narrowing of arterial walls, or restonosis, after cardiovascular procedures. This technology was recently introduced into the Indian medical... Read More

img-01

Double Standard for Counterfeit Drugs in India

Indian drug manufacturers and the International Federation of Pharmaceutical Manufacturers Association (IFPMA), which represents multinational, research-driven, pharmaceutical companies around the world, recently clashed over the production of counterfeit drugs in India. In late January 2003, IFPMA accused the Indian pharmaceutical industry of... Read More

img-01

Innovative Treatments for Cardiovascular Disease in Asia

As Asian countries begin to adopt more western lifestyles and foods, “western” diseases are becoming more prevalent killers in Asia. Economic transition, urbanization, and technological development have brought about lifestyle changes that have increased the chances for heart disease in Asia. Developing... Read More